Ian A. Myles

Dr. Ian A. Myles serves as a Principal Investigator at the Epithelial Therapeutics Unit within the Division of Intramural Research at the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. He is also Chief Medical Research Officer in the U.S. Public Health Service Commissioned Corps.

• Education: B.S. in Biology (Colorado State University, 2001), M.D. (University of Colorado, 2005), M.P.H. (George Washington University, 2016)
• Clinical Care: Provides direct patient care at the NIH Clinical Center

Research Interests focus on the interplay between the skin microbiome, epithelial immunity, and allergic diseases. Current work includes:

• Topical probiotic therapy for eczema using Roseomonas mucosa
• Mechanisms of Staphylococcus aureus susceptibility
• Microbiome dynamics in tissue repair and wound healing
• Dietary and environmental factors shaping host-microbe interactions

Publication Trends (5 most recent) show a consistent focus on microbiome-based therapies for skin diseases, particularly eczema, with parallel exploration of cytokine signaling pathways and host-microbe interactions in inflammatory skin conditions.

Scientific Recognition:

• Lasker Clinical Research Scholars Program
• Distinguished Scholars Program

Clinical Studies include trials on microbiome transplantation therapy for atopic dermatitis (NCT03018275) and investigations into Staphylococcus aureus immunity (NCT02262819).